Clinical trial NCT05631119 - References

Healthy — Biorepository of Biospecimen Samples in Matched Healthy Control Participants and Participants Diagnosed With Diabetic Kidney Disease, Chronic Kidney Disease, or Type 2 Diabetes

Citation(s)

•   Chuah S, Chew V
  High-dimensional immune-profiling in cancer: implications for immunotherapy. J Immunother Cancer. 2020 Feb;8(1):e000363. doi: 10.1136/jitc-2019-000363.
•   Garcia-Carro C, Vergara A, Bermejo S, Azancot MA, Sanchez-Fructuoso AI, Sanchez de la Nieta MD, Agraz I, Soler MJ
  How to Assess Diabetic Kidney Disease Progression? From Albuminuria to GFR. J Clin Med. 2021 Jun 5;10(11):2505. doi: 10.3390/jcm10112505.
•   Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J
  Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health. 2020 Mar;10(1):107-111. doi: 10.2991/jegh.k.191028.001.
•   Krassowski M, Das V, Sahu SK, Misra BB
  State of the Field in Multi-Omics Research: From Computational Needs to Data Mining and Sharing. Front Genet. 2020 Dec 10;11:610798. doi: 10.3389/fgene.2020.610798. eCollection 2020.
•   Kreeger K
  Immune Profiling: A New Opportunity for Drug Development. Penn Medicine News. February 14, 2019. Accessed: 20 October 2022. https://www.pennmedicine.org/news/news-blog/2019/february/immune-profiling-a-new-opportunity-for-drug-development
•   National Institute of Health (NIH): National Center for Advancing Translational Sciences
  Understanding Translational Research Tools: Biorepository. Accessed: 19 October 2022. https://toolkit.ncats.nih.gov/module/discovery/developing-translational-research-tools/biorepository/
•   Olivier M, Asmis R, Hawkins GA, Howard TD, Cox LA
  The Need for Multi-Omics Biomarker Signatures in Precision Medicine. Int J Mol Sci. 2019 Sep 26;20(19):4781. doi: 10.3390/ijms20194781.
•   Quezada H, Guzman-Ortiz AL, Diaz-Sanchez H, Valle-Rios R, Aguirre-Hernandez J
  Omics-based biomarkers: current status and potential use in the clinic. Bol Med Hosp Infant Mex. 2017 May-Jun;74(3):219-226. doi: 10.1016/j.bmhimx.2017.03.003. Epub 2017 May 10.
•   Roy S, Schweiker-Kahn O, Jafry B, Masel-Miller R, Raju RS, O'Neill LMO, Correia CR, Trivedi A, Johnson C, Pilot C, Saddemi J, Memon A, Chen A, McHugh SP, Patel S, Daroshefski NM, Nguyen T, Wissler W, Sharma E, Hunter K
  Risk Factors and Comorbidities Associated with Diabetic Kidney Disease. J Prim Care Community Health. 2021 Jan-Dec;12:21501327211048556. doi: 10.1177/21501327211048556.
•   Siwek M
  An Overview of Biorepositories-Past, Present, and Future. Mil Med. 2015 Oct;180(10 Suppl):57-66. doi: 10.7205/MILMED-D-15-00119.
•   Strimbu K, Tavel JA
  What are biomarkers? Curr Opin HIV AIDS. 2010 Nov;5(6):463-6. doi: 10.1097/COH.0b013e32833ed177.
•   Subramanian I, Verma S, Kumar S, Jere A, Anamika K
  Multi-omics Data Integration, Interpretation, and Its Application. Bioinform Biol Insights. 2020 Jan 31;14:1177932219899051. doi: 10.1177/1177932219899051. eCollection 2020.

Biorepository of Biospecimen Samples in Matched Healthy Control Participants and Participants Diagnosed With Diabetic Kidney Disease, Chronic Kidney Disease, or Type 2 Diabetes

Details for clinical trial NCT05631119